NON-INVASIVE CANCER SOLUTIONS
Safe | Accurate | Easy on the Patient
WORLDWIDE
Outstanding Benefits for Patients

Outstanding Benefits for Patients



Encyclopedic Tumor Analysis Offers Viable Efficacious Treatment Options in Advanced Refractory Head and Neck Cancers
In Press


Clinical Efficacy of Combination Therapies with Androgen Receptor Antagonists for Treatment of Multiple Refractory Cancers
DOI: 10.1200/JGO.2019.5.suppl.115 Journal of Global Oncology 5, no. suppl (October 07, 2019) 115-115

Encyclopedic Tumor Analysis Guided Treatments with Conventional Drugs Outperform Available Alternatives in Refractory Cancers
Annals of Oncology. 2019 Nov 1;30(Supplement_7):mdz413-098

mTOR Inhibitors in Combination Regimens Guided by Encyclopedic Tumour Analysis Show Superior Outcomes Compared to Monotherapy in Refractory Cancers
Annals of Oncology. 2019 Nov 1;30(Supplement_7):mdz413-115

Encyclopedic Tumour Analysis (ETA) Guided Combination Regimens of Hormone Receptor Antagonists with Other Systemic Agents for Treatment of Refractory Cancers
Annals of Oncology. 2019 Nov 1;30(Supplement_7):mdz413-106

Circulating Tumour Associated Cells in Esophageal Cancers are Resistance Educated Per Previous Chemo Treatments
Annals of Oncology. 2019 Nov 1;30(Supplement_7):mdz413-050

Clinical Utility of Encyclopedic Tumour Analysis to Treat Patients with Advanced Refractory Head and Neck Cancers
Annals of Oncology, Volume 30, Issue Supplement_9, November 2019, mdz431.008

Clinical Utility of Encyclopedic Tumor Analysis to Treat Patients with Brain Metastasis in Refractory Cancers
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Pages vi59–vi60

In Vitro Chemo Resistance Profiles of Circulating Glial Cells Replicate Chemo Characteristics of Tumor Tissue
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi135



Encyclopedic Tumor Analysis Guided Treatments with Conventional Drugs Outperform Available Alternatives in Refractory Head and Neck Cancers
In Press

Clinical Utility of Encyclopedic Tumor Analysis to Treat Breast Cancer Patients who have Failed Standard of Care Treatments
In Press

Circulating Tumor Associated Cells in Breast Cancers are Resistance Educated towards Prior Anthracycline Treatments
In Press

Real-time Non-Invasive Chemoresistance Profiling of Circulating Tumor Associated Cells in Breast Cancers to Determine Resistance towards Mitotic Inhibitors
In Press
CONTACT US